1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ: The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010, 25:544-551.
2. Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, Wei Z, Song X, Wang X, Fu S, et al: Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod 2013, 28:2562-2569.
3. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO: Polycystic ovary syndrome. Nat Rev Dis Primers 2016, 2:16057.
4. Thessaloniki EA-SPCWG: Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008, 23:462-477.
5. Timmons D, Montrief T, Koyfman A, Long B: Ovarian hyperstimulation syndrome: A review for emergency clinicians. Am J Emerg Med 2019, 37:1577-1584.
6. Qiao J, Feng HL: Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 2011, 17:17-33.
7. Kuang Y, Chen Q, Fu Y, Wang Y, Hong Q, Lyu Q, Ai A, Shoham Z: Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 2015, 104:62-70 e63.
8. Wang Y, Chen Q, Wang N, Chen H, Lyu Q, Kuang Y: Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial. Medicine (Baltimore) 2016, 95:e2939.
9. Lu X, Hong Q, Sun L, Chen Q, Fu Y, Ai A, Lyu Q, Kuang Y: Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist. Fertil Steril 2016, 106:1356-1362.
10. Ye H, Tian H, He W, Lyu Q, Kuang Y, Chen Q, Sun L: Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome. Reprod Biol Endocrinol 2018, 16:53.
11. Jiang S, Kuang Y: Clomiphene citrate is associated with favorable cycle characteristics but impaired outcomes of obese women with polycystic ovarian syndrome undergoing ovarian stimulation for in vitro fertilization. Medicine (Baltimore) 2017, 96:e7540.
12. Requena A, Herrero J, Landeras J, Navarro E, Neyro JL, Salvador C, Tur R, Callejo J, Checa MA, Farre M, et al: Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update 2008, 14:571-582.
13. Roque M, Tostes AC, Valle M, Sampaio M, Geber S: Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynecol Endocrinol 2015, 31:917-921.
14. Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, et al: Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014, 371:119-129.
15. Rotterdam EA-SPCWG: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25.
16. Qin N, Chen Q, Hong Q, Cai R, Gao H, Wang Y, Sun L, Zhang S, Guo H, Fu Y, et al: Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 2016, 106:334-341 e331.
17. Xu X, Pommier S, Arbov T, Hutchings B, Sotto W, Foxcroft GR: In vitro maturation and fertilization techniques for assessment of semen quality and boar fertility. J Anim Sci 1998, 76:3079-3089.
18. Henkel RR, Schill WB: Sperm preparation for ART. Reprod Biol Endocrinol 2003, 1:108.
19. Liu DY, Clarke GN, Baker HW: Relationship between sperm motility assessed with the Hamilton-Thorn motility analyzer and fertilization rates in vitro. J Androl 1991, 12:231-239.
20. Cummins JM, Breen TM, Harrison KL, Shaw JM, Wilson LM, Hennessey JF: A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J In Vitro Fert Embryo Transf 1986, 3:284-295.
21. Kuang Y, Hong Q, Chen Q, Lyu Q, Ai A, Fu Y, Shoham Z: Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertil Steril 2014, 101:105-111.
22. Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, Shoham Z: Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online 2014, 29:684-691.
23. Liu Y, Chen Q, Yu S, Wang Y, He W, Chang HY, Wang B, Gao H, Long H, Wang L, et al: Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization/intracytoplasmic sperm injection: A prospective randomized controlled trial. Clin Endocrinol (Oxf) 2018, 88:442-452.
24. Wang Y, Kuang Y, Chen Q, Cai R: Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial. Trials 2018, 19:455.
25. Garcia-Velasco JA: The use of aromatase inhibitors in in vitro fertilization. Fertil Steril 2012, 98:1356-1358.
26. Huirne JA, van Loenen AC, Schats R, McDonnell J, Hompes PG, Schoemaker J, Homburg R, Lambalk CB: Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy. Hum Reprod 2005, 20:359-367.
27. Tarlatzis BC, Grimbizis G: The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization. J Assist Reprod Genet 1997, 14:1-4.
28. Skorupskaite K, George JT, Anderson RA: The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update 2014, 20:485-500.
29. He W, Li X, Adekunbi D, Liu Y, Long H, Wang L, Lyu Q, Kuang Y, O'Byrne KT: Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats. Sci Rep 2017, 7:8096.
30. Oride A, Kanasaki H, Tumurbaatar T, Zolzaya T, Okada H, Hara T, Kyo S: Effects of the Fertility Drugs Clomiphene Citrate and Letrozole on Kiss-1 Expression in Hypothalamic Kiss-1-Expressing Cell Models. Reprod Sci 2020, 27:806-814.
31. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF, Jr.: Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 1988, 66:165-172.
32. Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F: Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 1976, 57:1320-1329.
33. Moore AM, Campbell RE: Polycystic ovary syndrome: Understanding the role of the brain. Front Neuroendocrinol 2017, 46:1-14.
34. Goldrat O, Gervy C, Englert Y, Delbaere A, Demeestere I: Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients. Hum Reprod 2015, 30:2184-2189.
35. Yang AM, Cui N, Sun YF, Hao GM: Letrozole for Female Infertility. Front Endocrinol (Lausanne) 2021, 12:676133.
36. Andersen CY, Lossl K: Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Mullerian hormone and inhibin-B. Fertil Steril 2008, 89:1760-1765.
37. Rose BI, Brown SE: A review of the physiology behind letrozole applications in infertility: are current protocols optimal? J Assist Reprod Genet 2020, 37:2093-2104.
38. Hugues JN, Soussis J, Calderon I, Balasch J, Anderson RA, Romeu A, Recombinant LHSG: Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study. Hum Reprod 2005, 20:629-635.
39. Abbara A, Vuong LN, Ho VNA, Clarke SA, Jeffers L, Comninos AN, Salim R, Ho TM, Kelsey TW, Trew GH, et al: Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte. Front Endocrinol (Lausanne) 2018, 9:193.
40. Rosen MP, Shen S, Dobson AT, Rinaudo PF, McCulloch CE, Cedars MI: A quantitative assessment of follicle size on oocyte developmental competence. Fertil Steril 2008, 90:684-690.